Literature DB >> 6460557

Effect of methyldopa, clonidine, and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats.

B L Pegram, S Ishise, E D Frohlich.   

Abstract

Prolonged treatment of spontaneously hypertensive (SHR) rats with either methyldopa or clonidine significantly and similarly reduced mean arterial pressure. Heart rate increased with methyldopa but decreased with clonidine; other haemodynamic effects were similar. SHR treated methyldopa, but not clonidine, had significantly reduced cardiac masses and heart weight to body weight ratios than did rats receiving the vehicle. Normotensive Wistar Kyoto (WKY) rats treated with methyldopa also had lower cardiac masses than their controls, but exhibited no significant changes in systemic haemodynamics. Treatment with the vasodilator hydralazine increased cardiac output and decreased total peripheral resistance in both SHR and WKY, but the decrease in mean arterial pressure was significant only in SHR. Heart rate was decreased and heart weight to body weight in WKY was elevated. Cardiac mass did not change. Minimal changes in regional haemodynamics were noted, with hydralazine eliciting a decrease in most organ vascular resistances. The data indicate that regression of hypertrophy following antihypertensive therapy was not solely dependent upon haemodynamic factors; nor was it necessarily the effect of suppression of the adrenergic system, since the results obtained with methyldopa and clonidine was similar.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6460557     DOI: 10.1093/cvr/16.1.40

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  11 in total

1.  Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass.

Authors:  T Natsume; M B Kardon; B L Pegram; E D Frohlich
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

2.  Hypertension research program at ochsner: a program in translational research.

Authors:  Edward Frohlich
Journal:  Ochsner J       Date:  2002

3.  Haemodynamic effects of short and long term administration of felodipine in spontaneously hypertensive rats.

Authors:  M Nordlander
Journal:  Drugs       Date:  1985       Impact factor: 9.546

4.  An updated concept for left ventricular hypertrophy risk in hypertension.

Authors:  Edward D Frohlich
Journal:  Ochsner J       Date:  2009

5.  Left ventricular hypertrophy regression during antihypertensive treatment.

Authors:  H Eichstaedt; O Danne; R J Schroeder; D Kreuz
Journal:  Clin Investig       Date:  1992

6.  ANP expression in the hypertensive heart.

Authors:  Gania Kessler-Icekson; Yael Barhum; Jutta Schaper; Wolfgang Schaper; Ella Kaganovsky; Thomas Brand
Journal:  Exp Clin Cardiol       Date:  2002

7.  Immediate and prolonged hemodynamic effects of TA-3090 on spontaneously hypertensive (SHR) and normal Wistar-Kyoto (WKY) rats.

Authors:  T Isshiki; B L Pegram; E D Frohlich
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

8.  Evaluation of the effects of felodipine, verapamil and hydralazine on the survival rate of rats subjected to lethal effects of oxygen free radicals.

Authors:  S M Jacinto; B S Jandhyala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

9.  Effects of long term treatment with pinacidil and nifedipine on left ventricular anatomy and function in patients with mild to moderate systemic hypertension.

Authors:  F Steensgaard-Hansen; J E Carlsen
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 10.  Left ventricular hypertrophy and antihypertensive therapy.

Authors:  F H Messerli; S Oren; E Grossman
Journal:  Drugs       Date:  1988       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.